Fig. 1: Twenty-six studied global populations from five continents.
From: Genetic ancestry plays a central role in population pharmacogenomics
The samples consisted of 661, 347, 504, 489, and 503 African-, American-, East Asian-, South Asian- and European-ancestry individuals, respectively. The 661 African-ancestry individuals consisted of 61 individuals of African ancestry in the Southwestern United States (ASW), 96 African Caribbean in Barbados (ACB), 113 Gambian in the Western Division, Mandinka (GWD), 99 Esan in Nigeria (ESN), 85 Mende in Sierra Leone (MSL), 108 Yoruba in Ibadan, Nigeria (YRI), and 99 Luhya in Webuye, Kenya (LWK). The 347 American-ancestry individuals consisted of 64 individuals of Mexican ancestry in Los Angeles, California, USA (MXL), 104 Puerto Ricans in Puerto Rico (PUR), 94 Colombians in Medellin, Colombia (CLM), and 85 Peruvians in Lima, Peru (PEL). The 504 East Asian-ancestry individuals consisted of 104 Japanese in Tokyo, Japan (JPT), 103 Han Chinese in Beijing, China (CHB), 105 Southern Han Chinese, China (CHS), 93 Chinese Dai in Xishuangbanna, China (CDX), and 99 Kinh in Ho Chi Minh City, Vietnam (KHV). The 489 South Asian-ancestry individuals consisted of 96 Punjabi in Lahore, Pakistan (PJL), 86 Bengali in Bangladesh (BEB), 103 Gujarati Indians in Houston, Texas, USA (GIH), 102 Indian Telugu in the UK (ITU), and 102 Sri Lankan Tamil in the UK (STU). The 503 European-ancestry individuals consisted of 99 Utah residents (CEPH) with northern and western European ancestry (CEU), 107 individuals from Iberian populations in Spain (IBS), 91 British in England and Scotland (GBR), 99 Finnish in Finland (FIN), and 107 Toscani in Italia (TSI).
